386919002: Rituximab (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Immunomodulator\Immunosuppressant (substance)\Rituximab (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Immunosuppressant (substance)\Rituximab (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Rituximab (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Monoclonal antibody\Rituximab (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Rituximab (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Rituximab (substance)

\Biological substance (substance)\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Rituximab (substance)
\Biological substance (substance)\Immunologic substance (substance)\Antibody\Monoclonal antibody\Rituximab (substance)
\Biological substance (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Rituximab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461097016 Rituximab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1481033012 Rituximab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3263891000005119 rituximab da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Rituximab (substance)	Is a	Monoclonal antibody	true	Inferred relationship	Some
Rituximab (substance)	Is a	Immunosuppressant (substance)	true	Inferred relationship	Some
Rituximab (substance)	Is a	monoklonalt antistof-agens	false	Inferred relationship	Some
Rituximab (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance that modifies the immune response or the functioning of the immune system.	true	Inferred relationship	Some
Rituximab (substance)	Is a	murin-humant monoklonalt IgG-antistof	false	Inferred relationship	Some
Rituximab (substance)	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing rituximab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rituximab (substance)	Inferred relationship	Some	1
rituximab 10 mg/ml koncentrat til injektionsvæske, hætteglas a 10 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rituximab (substance)	Inferred relationship	Some
rituximab 10 mg/ml koncentrat til infusionsvæske, hætteglas a 50 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rituximab (substance)	Inferred relationship	Some
Rituximab 500mg infusion concentrate vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rituximab (substance)	Inferred relationship	Some
Rituximab 100mg infusion concentrate vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Rituximab (substance)	Inferred relationship	Some
Adverse reaction to rituximab administered by infusion	Causative agent	True	Rituximab (substance)	Inferred relationship	Some	1
Product containing rituximab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rituximab (substance)	Inferred relationship	Some	1
Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy)	Direct substance	True	Rituximab (substance)	Inferred relationship	Some	7
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen (regime/therapy)	Direct substance	True	Rituximab (substance)	Inferred relationship	Some	6
Rituximab therapy (procedure)	Direct substance	True	Rituximab (substance)	Inferred relationship	Some	2
Product containing precisely rituximab 100 milligram/10 milliliter conventional release solution for infusion vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Rituximab (substance)	Inferred relationship	Some	1
Product containing precisely rituximab 100 milligram/10 milliliter conventional release solution for infusion vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Rituximab (substance)	Inferred relationship	Some	1
Product containing precisely rituximab 500 milligram/50 milliliter conventional release solution for infusion vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Rituximab (substance)	Inferred relationship	Some	1
Product containing precisely rituximab 500 milligram/50 milliliter conventional release solution for infusion vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Rituximab (substance)	Inferred relationship	Some	1
Rituximab only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rituximab (substance)	Inferred relationship	Some	1
Rituximab only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Rituximab (substance)	Inferred relationship	Some	1
Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rituximab (substance)	Inferred relationship	Some	1
Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rituximab (substance)	Inferred relationship	Some	1
R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy	Direct substance	True	Rituximab (substance)	Inferred relationship	Some	2
Rituximab 10 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rituximab (substance)	Inferred relationship	Some	1
Rituximab 10 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rituximab (substance)	Inferred relationship	Some	1
Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Rituximab (substance)	Inferred relationship	Some	1
Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Rituximab (substance)	Inferred relationship	Some	1

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461097016	Rituximab (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481033012	Rituximab	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3263891000005119	rituximab	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)